Only one patient presented the well characterized BRAFV600E mutation; however, all patients showed NRAS mutations at different sites (G12V, Q61R, A146T, F156L), which is the second-most mutated gene in melanoma [30]. This evidence concerns the gene NRAS and melanoma.